Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric …

N Ughi, DP Bernasconi, F Del Gaudio… - Clinical Drug …, 2023 - Springer
Abstract Background and Objectives Remdesivir is an antiviral agent, which was shown to
be safe and effective in treating early COVID-19, but its favourable impact in hospitalised …
相关文章

Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric …

N Ughi, DP Bernasconi, F Del Gaudio… - Clinical drug …, 2023 - pubmed.ncbi.nlm.nih.gov
Background and objectives Remdesivir is an antiviral agent, which was shown to be safe
and effective in treating early COVID-19, but its favourable impact in hospitalised patients …

Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric …

N Ughi, D Bernasconi, F Del Gaudio… - CLINICAL DRUG …, 2023 - boa.unimib.it
Abstract Background and Objectives: Remdesivir is an antiviral agent, which was shown to
be safe and effective in treating early COVID-19, but its favourable impact in hospitalised …

Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric …

N Ughi, DP Bernasconi, F Del Gaudio… - Clinical Drug …, 2023 - europepmc.org
Methods In this monocentric retrospective cohort study, the effectiveness and safety of a 5-
day course of remdesivir (200 mg intravenously at Day 1, then 100 mg from Days 2-5) in …